| Typicality: | 0.411 |
| Saliency: | 0.301 |
| in patients with significant hepatic disease | 6 | other |
| to not generate higher costs | 3 | purpose |
| use → be used with → caution | 10 |
| use → be approached with → caution | 8 |
| use → be done with → caution | 8 |
| use → be → cautioned | 6 |
| use → be treated with → caution | 3 |
| use → be undertaken with → caution | 3 |
| negative | neutral | positive |
| 0.401 | 0.552 | 0.047 |
| Raw frequency | 38 |
| Normalized frequency | 0.301 |
| Modifier score | 0.600 |
| Perplexity | 18.281 |